Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Novartis (NVS) said that it has appointed Rob Kowalski, Global Head Regulatory Affairs and US Head of Drug Development, as Chief People & Organization Officer. He become a member of the Executive Committee of Novartis, effective September 1, 2021.


RTTNews | Jun 28, 2021 01:42AM EDT

01:42 Monday, June 28, 2021 (RTTNews.com) - Novartis (NVS) said that it has appointed Rob Kowalski, Global Head Regulatory Affairs and US Head of Drug Development, as Chief People & Organization Officer. He become a member of the Executive Committee of Novartis, effective September 1, 2021.

Kowalski is a senior drug development and regulatory executive with over 25 years of industry experience. Prior to his current role he has served in various leadership roles in the US and Europe.

Novartis noted that Steven Baert, currently Chief People & Organization Officer, will step down from the Executive Committee of Novartis, effective June 30, 2021 after 15 years with the company and almost 8 years in position. Vicki Rawlinson, US Head People & Organization will lead the function ad-interim until Kowalski takes over.

Read the original article on RTTNews ( https://www.rttnews.com/3205227/novartis-names-rob-kowalski-chief-people-organization-officer.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC